Literature DB >> 16269591

OSEM reconstruction, associated with temporal fourier and depth-dependant resolution recovery filtering, enhances results from sestamibi and 201Tl 16-interval gated SPECT.

Pierre-Yves Marie1, Wassila Djaballah, Philippe R Franken, Chris Vanhove, Marc A Muller, Henri Boutley, Sylvain Poussier, Pierre Olivier, Gilles Karcher, Alain Bertrand.   

Abstract

UNLABELLED: Gated SPECT recorded with 16 intervals determines left ventricular (LV) ejection fraction more accurately than does gated SPECT recorded with 8 intervals but produces higher image noise. This study aimed to assess the results from sestamibi and (201)Tl 16-interval gated SPECT when both signal-to-noise ratio and spatial resolution were enhanced with an original method of reconstruction.
METHODS: Forty patients with coronary artery disease underwent (201)Tl and sestamibi 16-interval gated SPECT and, to be used as a reference, cardiac MRI. Assessments of global and regional LV function provided by ordered-subsets expectation maximization (OSEM) with depth-dependant resolution recovery and temporal Fourier filtering were compared with those from conventional filtered backprojection (FBP) previously optimized by screening various filter frequencies and various temporal smoothing levels.
RESULTS: For both tracers, LV ejection fraction was determined best when the association of OSEM with depth-dependant resolution recovery was used alone, with temporal Fourier filtering, or with a slight 2-frame temporal smoothing: Mean absolute values of relative errors ranged from 3.2% to 3.6% (4.0%-7.9% for FBP), and coefficient correlation ranged from 0.91 to 0.93 (0.70-0.91 for FBP). Among these 3 reconstruction methods, the association of OSEM with depth-dependant resolution recovery with temporal Fourier filtering provided the highest signal-to-noise ratio, with mean increases of 54% for sestamibi and 80% for (201)Tl when compared with FBP, and the best analysis of segmental contractility, with exact agreement rates with MRI being 73% for (201)Tl and 79% for sestamibi.
CONCLUSION: OSEM associated with temporal Fourier filtering and depth-dependant resolution recovery filtering enhances the LV function assessment provided by sestamibi and (201)Tl 16-interval gated SPECT and dramatically reduces image noise, a property that enhances and facilitates image interpretation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269591

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

1.  Recommendations for reducing radiation exposure in myocardial perfusion imaging.

Authors:  Manuel D Cerqueira; Kevin C Allman; Edward P Ficaro; Christopher L Hansen; Kenneth J Nichols; Randall C Thompson; William A Van Decker; Marko Yakovlevitch
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

2.  Factors affecting the myocardial activity acquired during exercise SPECT with a high-sensitivity cardiac CZT camera as compared with conventional Anger camera.

Authors:  Antoine Verger; Laetitia Imbert; Yalcine Yagdigul; Renaud Fay; Wassila Djaballah; François Rouzet; Nicolas Fourquet; Sylvain Poussier; Véronique Roch; Dominique Le Guludec; Gilles Karcher; Pierre-Yves Marie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-08       Impact factor: 9.236

3.  Nuclear cardiology in the literature.

Authors:  Kenneth A Brown
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

4.  ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox.

Authors:  Sylvain Poussier; Fatiha Maskali; Nguyen Tran; Christophe Person; Pablo Maureira; Henri Boutley; Gilles Karcher; Patrick Lacolley; Véronique Régnault; Renaud Fay; Pierre Yves Marie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

5.  Routine evaluation of left ventricular function using CZT-SPECT, with low injected activities and limited recording times.

Authors:  Marine Claudin; Laetitia Imbert; Wassila Djaballah; Nicolas Veran; Sylvain Poussier; Véronique Roch; Mathieu Perrin; Antoine Verger; Henri Boutley; Gilles Karcher; Pierre-Yves Marie
Journal:  J Nucl Cardiol       Date:  2016-09-27       Impact factor: 5.952

6.  Nitrate-enhanced gated SPECT in patients with primary angioplasty for acute myocardial infarction: evidence of a reversible and nitrate-sensitive impairment of myocardial perfusion.

Authors:  Wassila Djaballah; Marc A Muller; Michael Angioï; Frédéric Moulin; Andrei Codreanu; Damien Mandry; Gérard Ethevenot; Gilles Karcher; Etienne Aliot; Pierre Y Marie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07-31       Impact factor: 9.236

7.  Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation.

Authors:  Pablo Maureira; Pierre-Yves Marie; Yihua Liu; Fengxu Yu; Sylvain Poussier; Fatiha Maskali; Frederique Groubatch; Gilles Karcher; Nguyen Tran
Journal:  Int J Cardiovasc Imaging       Date:  2013-02-13       Impact factor: 2.357

8.  Comparison between stress myocardial perfusion SPECT recorded with cadmium-zinc-telluride and Anger cameras in various study protocols.

Authors:  Antoine Verger; Wassila Djaballah; Nicolas Fourquet; François Rouzet; Grégoire Koehl; Laetitia Imbert; Sylvain Poussier; Renaud Fay; Véronique Roch; Dominique Le Guludec; Gilles Karcher; Pierre-Yves Marie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-27       Impact factor: 9.236

9.  Comparison of the dyssynchrony parameters recorded with gated SPECT in ischemic cardiomyopathy according to their repeatability at rest and to their ability to detect a synchrony reserve under dobutamine infusion.

Authors:  Damien Legallois; Pierre-Yves Marie; Philippe R Franken; Wassila Djaballah; Denis Agostini; Alain Manrique
Journal:  J Nucl Cardiol       Date:  2018-12-04       Impact factor: 5.952

10.  Filtering in SPECT Image Reconstruction.

Authors:  Maria Lyra; Agapi Ploussi
Journal:  Int J Biomed Imaging       Date:  2011-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.